Published in Law and Health Weekly, July 8th, 2006
The patent relates to the composition of antibody conjugate materials and the methods to enhance and preserve the attachment of radioactive molecules to therapeutic antibodies that are taken into certain diseased cells and subsequently kill them. A corresponding patent with a similar description was issued by the U.S. Patent and Trademark Office, as U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly